The Hidden Crisis: Why Long COVID Surveillance is Failing Millions For years, the official narrative surrounding the pandemic has relied on a narrow set of diagnostic tools. Yet, a groundbreaking study from Mass General Brigham published in JAMA Network Open suggests we have been looking at the wrong data. By deploying a precision-phenotyping AI algorithm, … Read more
Long COVID Drug BC007 Gets a Second Chance with New Biotech Firm APTA Therapeutics After a disappointing Phase 2 trial led to the insolvency of Berlin Cures, the future of BC007 – a potential treatment targeting the root causes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID – looked bleak. Now, a new biotech … Read more
Aging Lungs: The Hidden Link to Severe Flu and COVID-19 For years, scientists have known older adults face a significantly higher risk of severe illness from respiratory infections like influenza and COVID-19. Now, groundbreaking research from the University of California, San Francisco (UCSF) sheds light on why. The culprit? Aging lung cells, specifically fibroblasts, triggering … Read more
Vitamin D and Long COVID: A Potential Breakthrough? Recent research suggests a possible link between vitamin D supplementation and a reduced risk of developing long COVID symptoms. While high doses of vitamin D3 didn’t lessen the severity of initial COVID-19 infections or hospitalizations, a subtle signal emerged indicating a potential benefit for those experiencing lingering … Read more
The Long Shadow of Long Covid: A System Still Struggling to Respond Six years after the initial wave of Covid-19 swept across Vermont, a significant number of residents continue to grapple with the debilitating effects of long Covid. The condition, characterized by a wide range of symptoms including chronic fatigue, respiratory issues, and brain fog, … Read more
The Rising Economic Tide of Long COVID: New Research Offers Hope Long COVID is no longer a looming health crisis; it’s a significant drag on the US economy. Conservative estimates place the cost of existing cases at up to $6.6 billion (Bartsch et al., 2025). As understanding of this complex condition deepens, so does the … Read more
Unlocking Long COVID: How New Discoveries are Shaping the Future of Diagnosis and Treatment For many, the end of an acute COVID-19 infection doesn’t signal a return to normal. Instead, it marks the beginning of a frustrating and debilitating period known as Long COVID. Characterized by persistent symptoms like fatigue, brain fog, and shortness of … Read more
From Feline Ailment to Human Hope: How Cat Coronavirus Research Could Unlock Long COVID Secrets A seemingly isolated, often fatal disease in cats – feline infectious peritonitis, or FIP – is unexpectedly becoming a crucial battleground in the fight to understand and treat long COVID and other persistent inflammatory illnesses in humans. Recent research from … Read more
The Long Shadow of COVID: Emerging Trends in Long COVID Care and Research The initial waves of the COVID-19 pandemic may have subsided, but a significant challenge remains: Long COVID. Characterized by persistent symptoms weeks or months after the initial infection, Long COVID is reshaping healthcare landscapes and prompting a surge in research. This article … Read more
The Long Shadow of COVID: Diabetes, Endothelial Dysfunction, and the Promise of SGLT2 Inhibitors The acute phase of the COVID-19 pandemic may be receding, but a troubling aftereffect lingers: Long COVID. Emerging research, bolstered by studies from organizations like the CDC (CDC Long COVID Basics) and the OECD (OECD Long COVID Report), reveals a complex … Read more